CLINICAL_TRIALS
trial_result
· 2008-03-03
Clinical Trial Update: A Preliminary Clinical Study to Evaluate Fispemifene in the Treatment of Hypogonadism [Phase 2]
Summary
A Phase 2 clinical trial evaluating Fispemifene for hypogonadism has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: QuatRx Pharmaceuticals Company | Conditions: Hypogonadism | Phase 2 | Status: COMPLETED